Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Molecular & Cellular Oncology
|
September 19, 2019
Finding MYCure
Marie-Eve Beaulieu, Laura Soucek
Current Opinion in Pharmacology
|
May 4, 2019
Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead
Toni Jauset, Marie-Eve Beaulieu
Cells
|
April 26, 2020
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
Marie-Eve Beaulieu, Francisco Castillo, Laura Soucek
Frontiers in Cell and Developmental Biology
|
March 11, 2017
Strategies to Inhibit Myc and Their Clinical Applicability
Jonathan R Whitfield, Marie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)
|
July 17, 2023
Targeting MYC-driven lymphoma: lessons learned and future directions
Sandra Martínez-Martín, Marie-Eve Beaulieu, Laura Soucek
Expert Opinion on Therapeutic Targets
|
February 1, 2020
MYC, MYCL, and MYCN as therapeutic targets in lung cancer
Daniel Massó-Vallés, Marie-Eve Beaulieu, Laura Soucek
FEBS Letters
|
March 29, 2006
Inhibition of human matriptase by eglin c variants
Antoine Désilets, Jean-Michel Longpré, Marie-Eve Beaulieu, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 6, 2013
Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs
Marie-Eve Beaulieu, François-Olivier McDuff, Mikaël Bédard, et al.
Canadian Journal of Microbiology
|
June 11, 2025
Isolation, identification and community study of root fungal isolates from disturbed and undisturbed arctic and alpine tundra habitats in Northern Quebec, Canada
Léonie Côté, Godar Sene, Marie-Eve Beaulieu, et al.
The Biochemical Journal
|
October 27, 2006
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites
Brian J Holleran, Marie-Eve Beaulieu, Christophe D Proulx, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Molecular & Cellular Oncology
|
September 19, 2019
Finding MYCure
Marie-Eve Beaulieu, Laura Soucek
Current Opinion in Pharmacology
|
May 4, 2019
Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead
Toni Jauset, Marie-Eve Beaulieu
Cells
|
April 26, 2020
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
Marie-Eve Beaulieu, Francisco Castillo, Laura Soucek
Frontiers in Cell and Developmental Biology
|
March 11, 2017
Strategies to Inhibit Myc and Their Clinical Applicability
Jonathan R Whitfield, Marie-Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (Alhambra, Calif.)
|
July 17, 2023
Targeting MYC-driven lymphoma: lessons learned and future directions
Sandra Martínez-Martín, Marie-Eve Beaulieu, Laura Soucek
Expert Opinion on Therapeutic Targets
|
February 1, 2020
MYC, MYCL, and MYCN as therapeutic targets in lung cancer
Daniel Massó-Vallés, Marie-Eve Beaulieu, Laura Soucek
FEBS Letters
|
March 29, 2006
Inhibition of human matriptase by eglin c variants
Antoine Désilets, Jean-Michel Longpré, Marie-Eve Beaulieu, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 6, 2013
Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs
Marie-Eve Beaulieu, François-Olivier McDuff, Mikaël Bédard, et al.
Canadian Journal of Microbiology
|
June 11, 2025
Isolation, identification and community study of root fungal isolates from disturbed and undisturbed arctic and alpine tundra habitats in Northern Quebec, Canada
Léonie Côté, Godar Sene, Marie-Eve Beaulieu, et al.
The Biochemical Journal
|
October 27, 2006
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites
Brian J Holleran, Marie-Eve Beaulieu, Christophe D Proulx, et al.
Page
of 3